ADURO BIOTECH (ADRO) Covered Calls

Aduro Biotech Inc is a clinical-stage immuno-oncology company focused on the development of technology platforms designed to stimulate robust and durable immune responses against cancer.

You can sell covered calls on ADURO BIOTECH to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ADRO (prices last updated Mon 4:16 PM ET):

ADURO BIOTECH (ADRO) Stock Quote

Last

Change

Bid

Ask

Volume

P/E

Market Cap

3.02

-0.26

2.90

3.15

636K

-

0.3B

Covered Calls For ADURO BIOTECH (ADRO)

Expiration

Strike

Call Bid

Net Debit

ReturnIf Flat

AnnualizedReturn If Flat

Dec 21

2.5

0.40

2.75

-9.1%

-100.7%

Jan 18

2.5

0.00

3.15

-20.6%

-123.3%

Subscribers get access to the full covered call chain, and more features.

Aduro BioTech, Inc. operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms to stimulate an immune response against cancer. The company has ongoing clinical trials with its LADD platform in pancreatic cancer, mesothelioma and high-grade glioma and development programs in non-small cell lung cancer, ovarian cancer and prostate cancer. It is also developing clinical candidates using synthetic small molecule immune modulators that are designed to activate the intracellular STING receptor, a central mediator of the innate immune response. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.